Bridgefront Capital, LLC Cerus Corp Transaction History
Bridgefront Capital, LLC
- $278 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding CERS
# of Institutions
160Shares Held
144MCall Options Held
22.5KPut Options Held
23.6K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl20.8MShares$38.5 Million0.28% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$36 Million0.33% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$25.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$19.3 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.32MShares$15.4 Million0.06% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $328M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...